Page 5,101«..1020..5,1005,1015,1025,103..5,1105,120..»

BrainStorm Signs Memorandum of Understanding With PRC Clinical for US Clinical Trial Management

Posted: Published on June 27th, 2013

NEW YORK, NEW YORK and PETACH TIKVAH, ISRAEL--(Marketwired - Jun 26, 2013) - BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that it has signed a Memorandum of Understanding (MOU) with PRC Clinical, a Contract Research Organization (CRO) based in the San Francisco Bay Area, in anticipation of its planned Phase II multi-center ALS clinical trial in the United States. "We chose PRC Clinical to manage our upcoming US-based trial based on their comprehensive range of support services, their experience with both orphan drug trials and neurological disease, specifically ALS, and their use of state-of-the-art monitoring and management technologies," said Alon Natanson, BrainStorm's CEO. "PRC Clinical is delighted to have been selected as the CRO for this trial and we are committed to providing BrainStorm's clinical development program with the highest quality management and data," commented Curtis Head, President and CEO of PRC Clinical. BrainStorm is currently conducting a Phase IIa dose-escalating trial with 12 ALS patients at the Hadassah Medical Center in Jerusalem, Israel. The company anticipates launching a Phase II multi-center trial at three leading institutions in the United States towards the end of 2013, pending FDA approval. … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on BrainStorm Signs Memorandum of Understanding With PRC Clinical for US Clinical Trial Management

Stem Cell Therapy Becomes More Widely Available – Video

Posted: Published on June 27th, 2013

Stem Cell Therapy Becomes More Widely Available The average athlete may soon have access to the benefits of stem cell research. By: ABCNews … Continue reading

Comments Off on Stem Cell Therapy Becomes More Widely Available – Video

Thor's Video Diary on May 16, 2013 Just about 14 weeks after stem cell treatmen – Video

Posted: Published on June 27th, 2013

Thor's Video Diary on May 16, 2013 Just about 14 weeks after stem cell treatmen A short video of Thor and his progress on May 16, 2013 He continues to do very well. He has regained much muscle tone in his left hind leg - he lost a lot be... By: Wendy Schindler … Continue reading

Comments Off on Thor's Video Diary on May 16, 2013 Just about 14 weeks after stem cell treatmen – Video

SONA: PMA, nagbabala laban sa iligal na stem cell treatment – Video

Posted: Published on June 27th, 2013

SONA: PMA, nagbabala laban sa iligal na stem cell treatment State of the Nation is a nightly newscast anchored by award-winning broadcast journalist, Jessica Soho. It airs Mondays to Fridays at 9:00 PM (PHL Time) on G... By: gmanews … Continue reading

Comments Off on SONA: PMA, nagbabala laban sa iligal na stem cell treatment – Video

Cancer Treatment Center Of America Opening Stem Cell Center In NE Phila.

Posted: Published on June 27th, 2013

file photo (Credit: SAM PANTHAKY/AFP/Getty Images) By Lynne Adkins PHILADELPHIA (CBS) - A local facility is opening a new unit to help patients with certain types of cancer. The stem cell transplant center at Cancer Treatment Centers of America in Northeast Philadelphia will help patients with such cancers as leukemia, lymphoma, and multiple myeloma. Dr. Pamela Crilley, chief of medical oncology, says the 17,000 square foot facility has eight rooms for patients undergoing stem cell transplants and more. It has a dedicated infusion center for outpatient treatments and it also has a apheresis section where we will collect stem cells. It has cryopreservation laboratory, Dr. Crilley said this unit will allow the center to treat patients locally, instead of sending them to facilities in other parts of the country. We have five facilities and so they may have been treated in a different facility than our location here, so this is really expanding what can be done at this location. Originally posted here: Cancer Treatment Center Of America Opening Stem Cell Center In NE Phila. … Continue reading

Comments Off on Cancer Treatment Center Of America Opening Stem Cell Center In NE Phila.

House seeks probe on stem-cell therapy link to solons' deaths

Posted: Published on June 27th, 2013

Should there be a law on stem cell therapy? The House of Representatives (HOR) has no idea. And for the sake of finding answer, House leaders intend to consult with medical experts about the issues surrounding the procedure. Speaker Feliciano Sonny Belmonte Jr. admits lawmakers need an expert opinion before they take any legislative action on reports about the negative effects of the expensive treatment. At this point, we have absolutely no basis to say that it was wrong (or) it wasnt wrong (or) it should be regulated, it should not be regulated, Belmonte said. Belmonte issued the statement after the Philippine Medical Association (PMA) said it is looking into the recent deaths of three politicians, who died after receiving xenogenic treatment in Germany. PMA president Dr. Leo Olarte said his group is still trying to find out whether politicians died due to their illness or due to hypersensitive reaction from animal-based stem cell treatments they received. On Monday, Belmonte revealed that Camiguin Rep. Pedro Romualdo underwent stem cell treatment in Germany before he died in April due to pneumonia. Incoming Bohol Rep. Aris Aumentado also admitted his father, the late Bohol Rep. Erico Aumentado, had undergone similar treatment in … Continue reading

Comments Off on House seeks probe on stem-cell therapy link to solons' deaths

International Stem Cell Corporation to Present Data From Its Parkinson's Disease Program at Society for Neuroscience …

Posted: Published on June 27th, 2013

CARLSBAD, CA--(Marketwired - Jun 27, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a California-based biotechnology company developing novel stem cell based therapies, announced today that it will present preliminary data from its IND-enabling study in Parkinson's disease at the Society for Neuroscience annual meeting in San Diego, CA on November 10th 2013. The Society for Neuroscience is the world's largest organization of scientists and clinicians devoted to understanding the brain and nervous system. More than 30,000 people are expected to attend the annual meeting, making it one of the largest scientific and medical conferences in the world. ISCO's Parkinson's disease program uses human parthenogenetic neural stem cells (hPNSC) which are a novel therapeutic cellular product derived from the company's proprietary histocompatible human pluripotent stem cells. hPNSC are self-renewing mulitpotent cells that are precursors for the major cells of the central nervous system. The ability of hPNSC to (i) differentiate into dopaminergic (DA) neurons and (ii) express neurotrophic factors such as glial derived neurotrophic factor (GDNF) and brain derived neurotrophic factor (BDNF) to protect the nigrostriatal system, offers a new opportunity for the treatment of Parkinson's disease, especially in cases where current small molecule approaches fail to adequately control … Continue reading

Comments Off on International Stem Cell Corporation to Present Data From Its Parkinson's Disease Program at Society for Neuroscience …

Giving hope: The promise of stem cell therapy

Posted: Published on June 27th, 2013

MANILA - As stem cell treatment begins to gain traction among Filipinos, a surgeon believes the country is now entering a new phase in medicine. Dr. Levi John Lansangan, one of the founding members of the Philippine Stem Cell Society, said there is much promise in stem cell therapy because of the hope it gives to ailing patients. "Before it was only physiologic, then it became pathologic, which deals with diseases. Then it became pharmacologic, wherein we give medicine. But now it is regenerative, wherein the body heals by itself," Lansangan told ANC's "Prime Time" on Wednesday. Stem cell treatment involves harvesting stem cells, processing them, and injecting them back to the body. Lansangan said the autologous treatment, which harvests stem cells from the patients own system, is the safest type of stem cell procedure. The procedure may last for up to 4 hours, depending on the patients health. It may cost up to P1.6 million. Stem cell treatment is believed to have the potential to cure illnesses including diabetes, heart ailments, brain damage such as Parkinsons and Alzheimers, osteoarthritis, stroke, baldness and even sports injuries. The hardest thing to say to a patient is hopelessness. If you say there … Continue reading

Comments Off on Giving hope: The promise of stem cell therapy

The Science of Mesenchymal Stem Cells and Regenerative Medicine – Arnold Caplan PhD (Part 7 of 7) – Video

Posted: Published on June 27th, 2013

The Science of Mesenchymal Stem Cells and Regenerative Medicine - Arnold Caplan PhD (Part 7 of 7) In this final segment, Prof. Caplan discusses: Mesenchymal stem cells make anti-bacterial molecules, How retro-orbital injections of human MSCs cure mice wit... By: http://www.cellmedicine.comContinue reading

Posted in Mesenchymal Stem Cells | Comments Off on The Science of Mesenchymal Stem Cells and Regenerative Medicine – Arnold Caplan PhD (Part 7 of 7) – Video

Mesoblast Receives Clearance to Begin Phase 2 Clinical Trial of Mesenchymal Precursor Cells in Diabetic Nephropathy

Posted: Published on June 27th, 2013

NEW YORK, N.Y., June 25, 2013 (GLOBE NEWSWIRE) -- Key Points: Mesoblast has received ethics approvals to begin a clinical trial of its proprietary allogeneic, or "off-the-shelf", adult Mesenchymal Precursor Cells (MPCs) in people with chronic kidney disease and type 2 diabetes . Trial is a randomized, double-blind placebo-controlled dose escalation study to evaluate the safety, tolerability and effectiveness of a single intravenous infusion of MPCs over an initial period of three months in patients with Stage 3b or 4 diabetic nephropathy . Mechanisms of action, based on preclinical studies, may include immunomodulation and reduction of kidney inflammation, reversal of abnormal kidney blood flow, and repair/regeneration of kidney tissue . Mesoblast's intravenous product is currently being evaluated in a range of inflammatory/immunologic conditions where the immunomodulatory properties of MPCs may provide substantial benefits, including diabetic nephropathy, early type 2 diabetes, and rheumatoid arthritis. Melbourne, Australia; 26 June 2013 and New York, USA; 25 June 2013: Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today announced that it has received approvals from Australian ethics committees to commence a Phase 2 trial evaluating a single intravenous infusion of its proprietary allogeneic or "off-the-shelf" adult Mesenchymal Precursor Cells (MPCs) in patients with type 2 … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Mesoblast Receives Clearance to Begin Phase 2 Clinical Trial of Mesenchymal Precursor Cells in Diabetic Nephropathy

Page 5,101«..1020..5,1005,1015,1025,103..5,1105,120..»